These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12045399)

  • 1. Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease.
    Arlt S; Beisiegel U; Kontush A
    Curr Opin Lipidol; 2002 Jun; 13(3):289-94. PubMed ID: 12045399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
    Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
    Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
    Smith DG; Cappai R; Barnham KJ
    Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.
    Butterfield DA; Castegna A; Lauderback CM; Drake J
    Neurobiol Aging; 2002; 23(5):655-64. PubMed ID: 12392766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.
    Butterfield DA; Drake J; Pocernich C; Castegna A
    Trends Mol Med; 2001 Dec; 7(12):548-54. PubMed ID: 11733217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease.
    Matsuoka Y; Picciano M; La Francois J; Duff K
    Neuroscience; 2001; 104(3):609-13. PubMed ID: 11440793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.
    Butterfield DA; Lauderback CM
    Free Radic Biol Med; 2002 Jun; 32(11):1050-60. PubMed ID: 12031889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid beta peptide, 4-hydroxynonenal and apoptosis.
    Lovell MA; Markesbery WR
    Curr Alzheimer Res; 2006 Sep; 3(4):359-64. PubMed ID: 17017866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease.
    Kontush A
    Free Radic Biol Med; 2001 Nov; 31(9):1120-31. PubMed ID: 11677045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's amyloid-beta as a preventive antioxidant for brain lipoproteins.
    Kontush A
    Cell Mol Neurobiol; 2001 Aug; 21(4):299-315. PubMed ID: 11775062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and amyloid beta toxicity in Alzheimer's disease: intervention in a complex relationship by antioxidants.
    Chakrabarti S; Sinha M; Thakurta IG; Banerjee P; Chattopadhyay M
    Curr Med Chem; 2013; 20(37):4648-64. PubMed ID: 23834172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.
    Butterfield DA; Bader Lange ML; Sultana R
    Biochim Biophys Acta; 2010 Aug; 1801(8):924-9. PubMed ID: 20176130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
    Sharma S; Verma S; Kapoor M; Saini A; Nehru B
    Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein.
    Singh M; Dang TN; Arseneault M; Ramassamy C
    J Alzheimers Dis; 2010; 21(3):741-56. PubMed ID: 20634576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.
    Calingasan NY; Uchida K; Gibson GE
    J Neurochem; 1999 Feb; 72(2):751-6. PubMed ID: 9930749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease.
    Jakaria M; Belaidi AA; Bush AI; Ayton S
    J Neurochem; 2021 Dec; 159(5):804-825. PubMed ID: 34553778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidized Docosahexaenoic Acid Species and Lipid Peroxidation Products Increase Amyloidogenic Amyloid Precursor Protein Processing.
    Grimm MO; Haupenthal VJ; Mett J; Stahlmann CP; Blümel T; Mylonas NT; Endres K; Grimm HS; Hartmann T
    Neurodegener Dis; 2016; 16(1-2):44-54. PubMed ID: 26642316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress hypothesis in Alzheimer's disease.
    Markesbery WR
    Free Radic Biol Med; 1997; 23(1):134-47. PubMed ID: 9165306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oxidative stress and Alzheimer's disease].
    Jiménez-Jiménez FJ; Alonso-Navarro H; Ayuso-Peralta L; Jabbour-Wadih T
    Rev Neurol; 2006 Apr 1-15; 42(7):419-27. PubMed ID: 16602059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.